Article
Washington -- Artecoll, a new item in the increasingly broad array of permanent and semipermanent nonsurgical wrinkle-reduction options, on Feb. 28 took a big step toward FDA approval.
Allergan Medical Institute to Launch 3 New US Training Centers for Clinicians
The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition
Botox Cosmetic: Ethics, Empowerment, and Innovation
The Cutaneous Connection: Cosmetic Dermatology: Procedures and Practice
Chilukuri’s Approach to Safer Aesthetic Treatments
The Future of Body Contouring: Insights from David Goldberg, MD, JD